The ferroptosis activator RSL3, an inhibitor of the antioxidant system, directly inactivates GPX4 and inhibits tumour growth in a xenograft mouse model of BJeLR cell origin (Fuchs and Steller, 2011). This evidence concerns the gene GPX4 and neoplasm.